159 related articles for article (PubMed ID: 37771073)
1. ELP3 stabilizes c-Myc to promote tumorigenesis.
Zhao W; Ouyang C; Huang C; Zhang J; Xiao Q; Zhang F; Wang H; Lin F; Wang J; Wang Z; Jiang B; Li Q
J Mol Cell Biol; 2024 Apr; 15(9):. PubMed ID: 37771073
[TBL] [Abstract][Full Text] [Related]
2. FBXL6 governs c-MYC to promote hepatocellular carcinoma through ubiquitination and stabilization of HSP90AA1.
Shi W; Feng L; Dong S; Ning Z; Hua Y; Liu L; Chen Z; Meng Z
Cell Commun Signal; 2020 Jun; 18(1):100. PubMed ID: 32576198
[TBL] [Abstract][Full Text] [Related]
3. Recombinant human adenovirus-p53 injection induced apoptosis in hepatocellular carcinoma cell lines mediated by p53-Fbxw7 pathway, which controls c-Myc and cyclin E.
Tu K; Zheng X; Zhou Z; Li C; Zhang J; Gao J; Yao Y; Liu Q
PLoS One; 2013; 8(7):e68574. PubMed ID: 23840897
[TBL] [Abstract][Full Text] [Related]
4. Colorectal Cancer Stem Cells Acquire Chemoresistance Through the Upregulation of F-Box/WD Repeat-Containing Protein 7 and the Consequent Degradation of c-Myc.
Izumi D; Ishimoto T; Miyake K; Eto T; Arima K; Kiyozumi Y; Uchihara T; Kurashige J; Iwatsuki M; Baba Y; Sakamoto Y; Miyamoto Y; Yoshida N; Watanabe M; Goel A; Tan P; Baba H
Stem Cells; 2017 Sep; 35(9):2027-2036. PubMed ID: 28699179
[TBL] [Abstract][Full Text] [Related]
5. Zinc finger protein 746 promotes colorectal cancer progression via c-Myc stability mediated by glycogen synthase kinase 3β and F-box and WD repeat domain-containing 7.
Jung JH; Jung DB; Kim H; Lee H; Kang SE; Srivastava SK; Yun M; Kim SH
Oncogene; 2018 Jul; 37(27):3715-3728. PubMed ID: 29628506
[TBL] [Abstract][Full Text] [Related]
6. Elongator promotes the migration and invasion of hepatocellular carcinoma cell by the phosphorylation of AKT.
Xu Y; Zhou W; Ji Y; Shen J; Zhu X; Yu H; Guo J; Pang Z; Wei W
Int J Biol Sci; 2018; 14(5):518-530. PubMed ID: 29805303
[TBL] [Abstract][Full Text] [Related]
7. Lysine-52 stabilizes the MYC oncoprotein through an SCF
De Melo J; Kim SS; Lourenco C; Penn LZ
Oncogene; 2017 Dec; 36(49):6815-6822. PubMed ID: 28806398
[TBL] [Abstract][Full Text] [Related]
8. PLEK2 promotes cancer stemness and tumorigenesis of head and neck squamous cell carcinoma via the c-Myc-mediated positive feedback loop.
Zhao X; Shu D; Sun W; Si S; Ran W; Guo B; Cui L
Cancer Commun (Lond); 2022 Oct; 42(10):987-1007. PubMed ID: 36002342
[TBL] [Abstract][Full Text] [Related]
9. Loss of Fbxw7 synergizes with activated Akt signaling to promote c-Myc dependent cholangiocarcinogenesis.
Wang J; Wang H; Peters M; Ding N; Ribback S; Utpatel K; Cigliano A; Dombrowski F; Xu M; Chen X; Song X; Che L; Evert M; Cossu A; Gordan J; Zeng Y; Chen X; Calvisi DF
J Hepatol; 2019 Oct; 71(4):742-752. PubMed ID: 31195063
[TBL] [Abstract][Full Text] [Related]
10. The MAP3K13-TRIM25-FBXW7α axis affects c-Myc protein stability and tumor development.
Zhang Q; Li X; Cui K; Liu C; Wu M; Prochownik EV; Li Y
Cell Death Differ; 2020 Feb; 27(2):420-433. PubMed ID: 31186535
[TBL] [Abstract][Full Text] [Related]
11. CSIG promotes hepatocellular carcinoma proliferation by activating c-MYC expression.
Cheng Q; Yuan F; Lu F; Zhang B; Chen T; Chen X; Cheng Y; Li N; Ma L; Tong T
Oncotarget; 2015 Mar; 6(7):4733-44. PubMed ID: 25749381
[TBL] [Abstract][Full Text] [Related]
12. Tumor suppressor NDRG2 inhibits glycolysis and glutaminolysis in colorectal cancer cells by repressing c-Myc expression.
Xu X; Li J; Sun X; Guo Y; Chu D; Wei L; Li X; Yang G; Liu X; Yao L; Zhang J; Shen L
Oncotarget; 2015 Sep; 6(28):26161-76. PubMed ID: 26317652
[TBL] [Abstract][Full Text] [Related]
13. RANBP10 promotes glioblastoma progression by regulating the FBXW7/c-Myc pathway.
Hou J; Liu Y; Huang P; Wang Y; Pei D; Tan R; Zhang Y; Cui H
Cell Death Dis; 2021 Oct; 12(11):967. PubMed ID: 34671019
[TBL] [Abstract][Full Text] [Related]
14. Guttiferone K impedes cell cycle re-entry of quiescent prostate cancer cells via stabilization of FBXW7 and subsequent c-MYC degradation.
Xi Z; Yao M; Li Y; Xie C; Holst J; Liu T; Cai S; Lao Y; Tan H; Xu HX; Dong Q
Cell Death Dis; 2016 Jun; 7(6):e2252. PubMed ID: 27253416
[TBL] [Abstract][Full Text] [Related]
15. The F-box protein FBXL16 up-regulates the stability of C-MYC oncoprotein by antagonizing the activity of the F-box protein FBW7.
Morel M; Shah KN; Long W
J Biol Chem; 2020 Jun; 295(23):7970-7980. PubMed ID: 32345600
[TBL] [Abstract][Full Text] [Related]
16. IFITM3 upregulates c-myc expression to promote hepatocellular carcinoma proliferation via the ERK1/2 signalling pathway.
Min J; Hu J; Luo C; Zhu J; Zhao J; Zhu Z; Wu L; Yuan R
Biosci Trends; 2020 Jan; 13(6):523-529. PubMed ID: 31852866
[TBL] [Abstract][Full Text] [Related]
17. Deregulated expression of a novel component of TFTC/STAGA histone acetyltransferase complexes, rat SGF29, in hepatocellular carcinoma: possible implication for the oncogenic potential of c-Myc.
Kurabe N; Katagiri K; Komiya Y; Ito R; Sugiyama A; Kawasaki Y; Tashiro F
Oncogene; 2007 Aug; 26(38):5626-34. PubMed ID: 17334388
[TBL] [Abstract][Full Text] [Related]
18. TRIP13 promotes the cell proliferation, migration and invasion of glioblastoma through the FBXW7/c-MYC axis.
Zhang G; Zhu Q; Fu G; Hou J; Hu X; Cao J; Peng W; Wang X; Chen F; Cui H
Br J Cancer; 2019 Dec; 121(12):1069-1078. PubMed ID: 31740732
[TBL] [Abstract][Full Text] [Related]
19. Human UTP14a promotes colorectal cancer progression by forming a positive regulation loop with c-Myc.
Zhang J; Ren P; Xu D; Liu X; Liu Z; Zhang C; Li Y; Wang L; Du X; Xing B
Cancer Lett; 2019 Jan; 440-441():106-115. PubMed ID: 30343112
[TBL] [Abstract][Full Text] [Related]
20. NSD3S stabilizes MYC through hindering its interaction with FBXW7.
Gonzalez-Pecchi V; Kwan AK; Doyle S; Ivanov AA; Du Y; Fu H
J Mol Cell Biol; 2020 Jul; 12(6):438-447. PubMed ID: 31638140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
